10-Q/A: DarkPulse Inc. Amends Q3 2024 Filing, Cites Material Weaknesses in Controls and Ongoing Financial Challenges
Quarterly Report Amendment
DarkPulse Inc. has filed an amendment to its Q3 2024 report, citing material weaknesses in disclosure controls and ongoing financial concerns, including a significant net loss and going concern uncertainty.
Summary
- DarkPulse Inc. filed an amendment to its original Q3 2024 report to correct disclosures in management's discussion and analysis and financial statement notes.
- The company reported a net loss of $3.54 million for the nine months ended September 30, 2024, compared to a net loss of $19.9 million for the same period in 2023.
- Revenues for the nine months ended September 30, 2024, were $55,839, a significant decrease from $2.03 million in the same period of 2023.
- The company's current liabilities exceeded its current assets by $20.5 million as of September 30, 2024, and it has an accumulated deficit of $70.9 million.
- DarkPulse had $165,186 in cash as of September 30, 2024.
- The company's ability to continue as a going concern is dependent on securing additional financing.
- The company has identified material weaknesses in its disclosure controls and procedures.
- The company deconsolidated Optilan UK Limited and its subsidiaries, resulting in a loss on deconsolidation of $1.64 million.
Sentiment
Score: 2
Explanation: The document reveals significant financial distress, material weaknesses in controls, and a going concern warning, indicating a very negative outlook from an investment perspective.
Positives
- The net loss for the nine months ended September 30, 2024, was significantly lower at $3.54 million compared to $19.9 million for the same period in 2023.
- The company has taken steps to address its financial challenges by seeking additional capital and strategic partnerships.
- The company has resolved certain disputes with GS Capital Partners LLC, which is expected to reduce the distraction of expensive litigation.
Negatives
- The company's revenue for the nine months ended September 30, 2024, was significantly lower at $55,839 compared to $2.03 million for the same period in 2023.
- The company's current liabilities exceed its current assets by $20.5 million.
- The company has an accumulated deficit of $70.9 million.
- The company has a low cash balance of $165,186.
- Management has expressed substantial doubt about the company's ability to continue as a going concern.
- The company has identified material weaknesses in its disclosure controls and procedures.
- The company recorded a loss on deconsolidation of $1.64 million related to Optilan UK Limited.
- The company recorded an impairment loss of $2.03 million related to goodwill and intangible assets.
Risks
- The company's ability to continue as a going concern is dependent on securing additional financing.
- The company faces significant financial challenges, including a large accumulated deficit and negative working capital.
- The company has identified material weaknesses in its disclosure controls and procedures, which could lead to inaccurate financial reporting.
- The company's revenue has significantly decreased, raising concerns about its ability to generate future income.
- The company is involved in multiple legal proceedings, which could result in significant costs and diversion of management's attention.
- The company's reliance on equity financing may dilute existing shareholders' ownership.
Future Outlook
The company will require additional funding during the next twelve months to finance the growth of its current operations and achieve its strategic objectives, and is seeking to raise additional capital through private placement offerings and strategic partners.
Management Comments
- Management is actively pursuing additional sources of financing sufficient to generate enough cash flow to fund its operations for twelve months from the issuance date of these consolidated financial statements.
- Management cannot make any assurances that such financing will be secured.
- Management has expressed substantial doubt about the company's ability to continue as a going concern.
Industry Context
The company operates in the technology and security sectors, which are characterized by rapid innovation and intense competition. The company's financial challenges and operational issues may make it difficult to compete effectively with larger, more established players in the industry.
Comparison to Industry Standards
- The company's revenue of $55,839 for the nine months ended September 30, 2024, is significantly below the industry average for companies in the technology and security sectors.
- The company's net loss of $3.54 million for the nine months ended September 30, 2024, is also significantly higher than the industry average for companies of similar size.
- The company's negative working capital and accumulated deficit are also concerning when compared to industry benchmarks.
- The company's cash balance of $165,186 is significantly lower than the industry average for companies of similar size.
- The company's disclosure controls and procedures are not effective, which is a significant concern when compared to industry standards for financial reporting.
Legal Proceedings
- The company is involved in multiple legal proceedings, including Carebourn Capital, L.P. v. DarkPulse, Inc., More Capital, LLC v. DarkPulse, Inc. et al, Carebourn Capital et al v. Standard Registrar and Transfer et al, DarkPulse, Inc. v. FirstFire Global Opportunities Fund, LLC, and Eli Fireman, DarkPulse, Inc., et al v. Crown Bridge Partners, LLC, et al, GS Capital Partners, LLC v. DarkPulse, Inc., and TJM West, Inc v Thomas J McCarthy Family Limited Partnership.
- The company has won judgments in some cases, but is still awaiting decisions in others.
- The company is actively investigating potential legal claims against certain Twitter accounts, websites, and social media channels.
Related Party Transactions
- The company has various loans with related parties, including former majority shareholders of Remote Intelligence and Wildlife Specialists.
- The company had a SPAC transaction with Gladstone Acquisition Corp., which was terminated on January 24, 2024.
Stakeholder Impact
- Shareholders face significant risk due to the company's financial challenges and going concern uncertainty.
- Employees may be affected by potential cost-cutting measures or restructuring.
- Customers may be concerned about the company's ability to deliver products and services.
- Suppliers and creditors face increased risk of non-payment.
- The company's financial difficulties may impact its ability to attract and retain talent.
Next Steps
- The company is actively pursuing additional sources of financing.
- The company is targeting strategic partners to finalize product development and begin generating revenues.
- The company needs to address the material weaknesses in its disclosure controls and procedures.
- The company needs to resolve its ongoing legal proceedings.
Key Dates
| Date | Description |
|---|---|
| 2010-12-16 | DPTI issued a convertible Debenture to the University in exchange for Patents. |
| 2021-01-12 | The company's subsidiary entered into an operating lease agreement in Mumbai, India. |
| 2021-05-27 | The company's subsidiary entered into an operating lease agreement in Warwick, UK. |
| 2021-08-31 | The company's subsidiary entered into an operating lease agreement in Tempe, Arizona. |
| 2021-10-20 | The company's subsidiary entered into an operating lease agreement in Warwick, UK. |
| 2022-03-09 | The company entered into an operating lease agreement in Houston, Texas. |
| 2022-09-09 | The Company entered into a Joint Venture Agreement with Neural Signals Inc. |
| 2022-10-12 | The Company entered into and closed the Purchase Agreement to purchase shares of Gladstone Acquisition Corp. |
| 2023-05-03 | Eversheds Sutherland filed a petition to wind up Optilan (UK) Limited. |
| 2023-06-28 | The High Court of Justice in the UK issued a winding-up order for Optilan (UK) Limited. |
| 2023-07-03 | Optilan (UK) Limited received a letter from The Insolvency Service. |
| 2023-07-18 | Interview held between the Official Receivers Office and the CEO at time of dissolution. |
| 2023-08-07 | The Company entered into a convertible note for a principal of $57,750. |
| 2023-08-09 | Evelyn Partners was appointed Joint Liquidator for Optilan (UK) Limited. |
| 2023-09-29 | The Company entered into a convertible note for a principal of $57,750. |
| 2023-12-04 | The Company entered into a convertible note for a principal of $51,150. |
| 2024-01-17 | Amendment No. 01 to Convertible Debenture (Secured) Term Debenture with the University was effective. |
| 2024-07-24 | The Company entered into a Settlement Agreement with GS Capital Partners, LLC. |
| 2024-08-14 | The Company entered into a Third Amendment to the Equity Financing Agreement with GHS. |
| 2024-08-19 | The Eighth Judicial District Court in Clark County, Nevada approved the settlement agreement with GS Capital. |
| 2024-09-11 | The Company closed a sale agreement purchasing the right, title and interest of shares in Optilan India and Optilan Communication & Security Systems. |
| 2024-11-19 | Original filing date of the Quarterly Report on Form 10-Q for the period ended September 30, 2024. |
| 2024-12-12 | Date of the amended filing. |
Keywords
DarkPulse, financial results, going concern, disclosure controls, net loss, revenue, impairment, deconsolidation, legal proceedings, equity financing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.